相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mesenchymal stem cells for systemic therapy: Shotgun approach or magic bullets?
Susan M. Millard et al.
BIOESSAYS (2013)
NF-kappa B Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
Ryosuke Uchibori et al.
CANCER RESEARCH (2013)
A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Daniel J. Weiss et al.
CHEST (2013)
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)
Anders Bruun Mathiasen et al.
AMERICAN HEART JOURNAL (2012)
FRMD4A Upregulation in Human Squamous Cell Carcinoma Promotes Tumor Growth and Metastasis and Is Associated with Poor Prognosis
Stephen J. Goldie et al.
CANCER RESEARCH (2012)
Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy The POSEIDON Randomized Trial
Joshua M. Hare et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
Michaela R. Reagan et al.
JOURNAL OF BREAST CANCER (2012)
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
Ann H. Klopp et al.
STEM CELLS (2011)
TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
M. R. Loebinger et al.
BRITISH JOURNAL OF CANCER (2010)
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
D. Ross Camidge et al.
CLINICAL CANCER RESEARCH (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Stem cells as vectors for antitumour therapy
Michael R. Loebinger et al.
THORAX (2010)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Jeffrey M. Karp et al.
CELL STEM CELL (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Improved Autograft Survival of Mesenchymal Stromal Cells by Plasminogen Activator Inhibitor 1 Inhibition
Ian B. Copland et al.
STEM CELLS (2009)
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
Shannon Kidd et al.
STEM CELLS (2009)
A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies
Sebastien J. Hotte et al.
CLINICAL CANCER RESEARCH (2008)
Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids
Dario Barbone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
F. Anthony Greco et al.
LUNG CANCER (2008)
Characterization of human mesothelioma cell lines as tumor models for suicide gene therapy
Marlon R. Veldwijk et al.
ONKOLOGIE (2008)
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L. Belyanskaya et al.
MOLECULAR CANCER (2007)
Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2007)
Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells
Hong Xin et al.
STEM CELLS (2007)
Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells
Lata G. Menon et al.
STEM CELLS (2007)
Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs
Xian-cheng Chen et al.
CARCINOGENESIS (2006)
Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts
Y Hosokawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Human fetal mesenchymal stem cells as vehicles for gene delivery
J Chan et al.
STEM CELLS (2005)
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development
DA Fennell et al.
LANCET ONCOLOGY (2004)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines
WH Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Human mesenchymal stem cells maintain transgene expression during expansion and differentiation
K Lee et al.
MOLECULAR THERAPY (2001)
分享论文
